Stone H A, Edelman R D, McGarry J J
Department of Podiatric Surgery, Doctors Hospital, Denver, Colorado.
J Foot Ankle Surg. 1993 Mar-Apr;32(2):232-8.
The authors present a synthetic skin substitute, Epigard, which was developed in 1973 and has been used worldwide for temporary coverage of open wounds. Epigard is a two-layer, non-medicated wound dressing which approximates the function of human skin. The article discusses the proper indications and usage of Epigard, as well as post operative wound management and definitive wound closure decisions. A case presentation involving a serious diabetic wound infection is discussed. At Doctors Hospital, Epigard has become an important adjunctive therapy in wound management by improving wound healing time and decreasing patient hospital stay.
作者介绍了一种人工皮肤替代品Epigard，它于1973年研发，已在全球范围内用于开放性伤口的临时覆盖。Epigard是一种双层、无药物的伤口敷料，其功能近似于人类皮肤。本文讨论了Epigard的适用指征和用法，以及术后伤口处理和最终伤口闭合的决策。文中还讨论了一个涉及严重糖尿病伤口感染的病例。在医生医院，Epigard通过缩短伤口愈合时间和减少患者住院天数，已成为伤口处理中的一项重要辅助治疗手段。
